In addition, decreased level of Dicer expression was found to be related to advanced tumour stages or poor clinical outcome in melanoma 13, neuroblastoma 14, breast 15, lung 16, and ovarian cancers 17, and some PKC inhibitors can reach a similar conclusion. Here, PRRT2 is linked to melanoma.